Todd Asset Management LLC Sells 1,204 Shares of HCA Healthcare, Inc. $HCA

Todd Asset Management LLC trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA) by 1.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 121,835 shares of the company’s stock after selling 1,204 shares during the quarter. Todd Asset Management LLC’s holdings in HCA Healthcare were worth $51,926,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also bought and sold shares of HCA. Norges Bank bought a new position in shares of HCA Healthcare during the 2nd quarter worth $1,152,408,000. Pacer Advisors Inc. boosted its position in HCA Healthcare by 6,115.3% during the third quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock worth $388,309,000 after purchasing an additional 896,437 shares during the period. Viking Global Investors LP grew its stake in HCA Healthcare by 58.5% in the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after buying an additional 690,773 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of HCA Healthcare in the second quarter valued at $109,337,000. Finally, HRT Financial LP purchased a new stake in HCA Healthcare during the 2nd quarter worth about $81,596,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Bank of America upped their target price on shares of HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a report on Monday, October 27th. Jefferies Financial Group increased their price objective on HCA Healthcare from $535.00 to $590.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Sanford C. Bernstein set a $541.00 target price on HCA Healthcare in a research note on Monday, February 9th. Deutsche Bank Aktiengesellschaft boosted their price objective on HCA Healthcare from $500.00 to $558.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. Finally, Wall Street Zen lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Sixteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $523.27.

HCA Healthcare Stock Performance

HCA stock opened at $539.91 on Monday. The firm’s fifty day moving average is $482.80 and its 200 day moving average is $449.62. HCA Healthcare, Inc. has a 52 week low of $295.00 and a 52 week high of $552.90. The firm has a market cap of $120.73 billion, a P/E ratio of 19.02, a P/E/G ratio of 1.66 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping the consensus estimate of $7.37 by $0.64. The firm had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The company’s quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio is currently 10.15%.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA’s share performance is strong on a year‑over‑year basis (shares up ~75% YoY), reinforcing momentum and investor confidence in the company’s results and outlook. Read More.
• Positive Sentiment: Zacks and other analysts highlight earnings growth and price strength; Zacks added HCA to focus coverage and raised FY‑2026 EPS estimates, supporting forward earnings momentum and valuation. Read More.
• Positive Sentiment: HCA raised its quarterly dividend (new quarterly payout announced), which narrows yield risk and is a modest positive for income‑oriented investors. Read More.
• Positive Sentiment: Large institutional flows and stake increases (e.g., Norges Bank, Pacer, Viking Global) point to strong institutional demand and provide technical/supportive buying pressure for the stock. Read More.
• Neutral Sentiment: HCA completed a 43‑hospital EHR rollout and is tracking success metrics — operational execution that can improve efficiency and integration over time but has a gradual, not immediate, earnings impact. Read More.
• Neutral Sentiment: Local expansion moves — HCA Houston Healthcare Tomball acquired Supreme Care ER and StoneSprings plans a freestanding ER conversion — small, market‑level capacity adds that could modestly lift volumes in those geographies. Read More.
• Neutral Sentiment: HCA sold ASC real estate — a financing/portfolio move that could free capital or change lease terms; impact depends on transaction use of proceeds. Read More.
• Negative Sentiment: Insider selling: two senior VPs disclosed multi‑million dollar sales (Christopher Wyatt sold ~$2.0M; Jennifer Berres sold ~$4.13M). Significant insider sales can create short‑term selling pressure or raise governance/portfolio‑rebalancing questions. Read More. Read More.
• Negative Sentiment: Zacks/other outlets flagged a downward revision to HCA’s Q1 EPS forecast, which can pressure near‑term expectations even as FY estimates were raised. Read More.

Insider Activity

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the transaction, the senior vice president directly owned 44,379 shares of the company’s stock, valued at approximately $22,411,395. The trade was a 8.27% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael S. Cuffe sold 1,500 shares of HCA Healthcare stock in a transaction dated Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the sale, the executive vice president directly owned 30,003 shares in the company, valued at $14,944,194.27. The trade was a 4.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 13,520 shares of company stock valued at $6,894,067. Insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.